Acromegalic heart disease

Endocrinologist

Volumn 8, Issue 4, 1998, Pages 273-278

  Pinzone, Joseph J ^a   Katznelson, Laurence ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEART CONDUCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; MYOCARDIAL DISEASE; NONHUMAN; RADIOTHERAPY; RAT;

EID: 0031858817     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199807000-00007     Document Type: Article

References (36)

1. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK: Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994; 41: 95-102.
2. Bengtsson B-A, Eden S, Ernest I, Oden A, Sjogren B: Epidemiology and long-term survival in acromegaly. Acta Med Scand 1988; 223: 327-35.
3. Engelmann GL, Boehm KD, Haskell JF, Khairallah PA, Ilan J: Insulin-like growth factors and neonatal cardiomyocytes development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Mol Cell Endocrinol 1989; 63: 1-14.
4. Hanson MC, Fath KA, Alexander RW, Delafontaine P: Induction of cardiac insulin-like growth factor I gene expression in pressure overload hypertrophy. Am J Med Sci 1993; 306: 69-74.
5. Donohue TJ, Dworkin LD, Lango MN, et al.: Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994; 89: 799-809.
6. Wahlander H, Isgaard J, Jennische E, Friberg P: Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992; 19: 25-32.
7. Ito H, Hiroe M, Hirata Y, et al.: Insulinlike growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-21.
8. Gilbert PL, Siegel RJ, Melmed S, Sherman CT, Fishbein MC: Cardiac morphology in rats with growth hormone-producing tumours. J Mol Cell Cardiol 1985; 17: 805-11.
9. Timsit J, Riou B, Bertherat J, et al.: Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990; 86: 507-15.
10. Rubin SA, Buttrick P, Malhotra A, Melmed S, Fishbein MC: Cardiac physiology, biochemistry and morphology in response to excess growth hormone in the rat. J Mol Cell Cardiol 1990; 22: 429-38.
11. Penney DG, Dunbar Jr JC, Baylerian MS: Cardiomegaly and haemodynamics in rats with a transplantable growth hormone-secreting tumour. Cardiovasc Res 1985; 19: 270-7.
12. Xu X, Best PM: Decreased transient outward K+ current in ventricular myocytes from acromegalic rats. Am J Physiol 1991; H935-12.
13. Mayoux E, Ventura-Clapier R, Timsit J, Behar-Cohen F, Hoffman C, Mercadier J-J: Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res 1992; 72: 57-64.
14. Lie JT, Grossman SJ: Pathology of the heart in acromegaly: anatomic finkings in 27 autopsied patients. Am Heart J 1980; 100: 41-52.
15. Gravanis MB, Sternby NH: Incidence of myocarditis. A 10-year autopsy study from Malmo, Sweden. Arch Pathol Lab Med 1991; 115: 390-2.
16. Passarino G, Burlo P, Ciccone G, et al.: Prevalence of myocarditis at autopsy in Turin, Italy. Arch Pathol Lab Med 1997; 121: 619-22.
17. Thuesen L, Christensen SE, Weeke J, Orskov H, Henningsen P: A hyperkinetic heart in uncomplicated active acromegaly. Acta Med Scand 1988; 223: 337-43.
18. Fazio S, Cittadini A, Cuocolo A, et al.: Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994; 79: 441-6.
19. Lusiani L, Ronsisvalle G, Visona A, et al.: Acromegalic cardiomyopathy: an echocardiographic study. J Endocrinol Invest 1988; 11: 159-64.
20. Martins JB, Kerber RE, Sherman BM, Marcus ML, Ehrhardt JC: Cardiac size and function in acromegaly. Circulation 1977; 56: 863-9.
21. Fazio S, Cittadini A, Sabatini D, et al.: Evidence for biventricular involvement in acromegaly: a doppler echocardiographic study. Eur Heart J 1993; 14: 26-33.
22. Morvan D, Komajda M, Grimaldi A, Turpin G, Grosgogeat Y: Cardiac hypertrophy and function in asymptomatic acromegaly. Eur Heart J 1991; 12: 666-72.
23. Lopez-Velasco R, Escobar-Morreale HF, Vega B, et al.: Cardiac involvement in acromegaly: specific myocadiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab 1997; 82: 1047-53.
24. Sicolo N, Bui F, Sicolo M, et al.: Acromegalic cardiopathy: a left ventricular scintigraphic study. J Endocrinol Invest 1993; 16: 123-7.
25. Cuocolo A, Nicolai E, Fazio S, et al.: Impaired left ventricular diastolic filling in patients with acromegaly: assessment with radionuclide angiography. J Nucl Med 1995; 36: 196-201.
26. Rodrigues EA, Caruana MP, Lahiri A, Nabarro JDN, Jacobs H, Braftery EB: Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J 1989; 62: 185-94.
27. Kahaly G, Stover C, Beyer J, Mohr-Kahaly S: Relation of endocrine and cardiac findings in acromegalics. J Endocrinol Invest 1992; 15: 13-8.
28. Pepine CJ, Aloia J: Heart muscle disease in acromegaly. Am J Med 1970; 48: 530-4.
29. Baldwin A, Cundy T, Butler J, Timmis AD: Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinol 1985; 108: 26-30.
30. Barkan AL, Halasz I, Dornfeld KJ, et al.: Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997; 82: 3187-91.
31. Lim MJ, Barkan AL, Buda AJ: Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med 1992; 117: 719-26.
32. Merola B, Cittadini A, Colao A, et al.: Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metab 1993; 77: 790-3.
33. Thuesen L, Christensen SE, Weeke J, Orskov H, Henningsen P: The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin Endocrinol 1989; 30: 619-25.
34. Giustina A, Boni E, Romanelli G, Grassi V, Giustina G: Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 1995; 75: 1042-7.
35. Chanson P, Timsit J, Masquet C, et al.: Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 1990; 113: 921-5.
36. Hradec J, Marek J, Kral J, Janota T, Poloniecke J, Malik M: Long-term echocardiographic follow-up of acromegalic heart disease. Am J Cardiol 1993; 72: 205-10.